FPN || News

Antipsychotics’ risk in dementia revised upward

Posted on: 08/04/2014 - 05:01

ORLANDO – The mortality risk associated with prescription of antipsychotics or valproic acid for behavioral disturbances in patients with dementia is considerably greater than previously estimated,...

Field of Interest: Geriatrics
Type: News Item

Milk may slow knee OA progression in women

Posted on: 07/04/2014 - 19:45

Milk consumption was associated with a slowing of the structural progression of knee osteoarthritis among women who participated in the longitudinal Osteoarthritis Initiative study. From a group of...

Field of Interest: Rheumatology
Type: News Item

Milk may slow knee OA progression in women

Posted on: 07/04/2014 - 19:45

Milk consumption was associated with a slowing of the structural progression of knee osteoarthritis among women who participated in the longitudinal Osteoarthritis Initiative study. From a group of...

Field of Interest: Pulmonology
Type: News Item

Dabigatran approved for VTE prevention and treatment

Posted on: 07/04/2014 - 17:35

The novel oral anticoagulant dabigatran has been approved for treating and reducing the risk of recurrence of deep venous thrombosis and pulmonary embolism, based on the results of four phase III...

Field of Interest: Cardiology
Type: News Item

VIDEO: PCSK9 inhibitors placed in perspective

Posted on: 07/04/2014 - 16:55

WASHINGTON – "We’re at the dawn of an era of biological therapeutics in cardiology," Dr. Peter Libby, chief of cardiovascular medicine at the Brigham and Women’s Hospital in Boston, told us...

Field of Interest: Cardiology
Type: News Item

VIDEO: Exploring SYMPLICITY’s failure, Part 2

Posted on: 04/04/2014 - 18:35

WASHINGTON – Far from being doomed after the failure SYMPLICITY HTN-3, renal denervation for refractory hypertension will continue to be explored. But it can’t go very far without finding a way to...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More